Beam Therapeutics BEAM Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's total current liabilities?
- Beam Therapeutics (BEAM) reported total current liabilities of $74.57M in Q1 2026.
- How has Beam Therapeutics's total current liabilities changed year-over-year?
- Beam Therapeutics's total current liabilities decreased by 47.3% year-over-year, from $141.55M to $74.57M.
- What is the long-term trend for Beam Therapeutics's total current liabilities?
- Over 5 years (2020 to 2025), Beam Therapeutics's total current liabilities has grown at a -1.1% compound annual growth rate (CAGR), from $102.34M to $96.94M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.